Related Experiment Video
Updated: Sep 4, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Pathophysiology and Repair Potential in Degenerative Cervical Myelopathy
Sebastian A Lares1, Nader Hejrati2, James D Guest3
1The Miami Project to Cure Paralysis, Miller School of Medicine, Miami, FL, USA.
Abstract:
Degenerative cervical myelopathy (DCM) is a chronic spinal cord disorder caused by progressive compression leading to ischemia, cell death, inflammation, demyelination, and network reorganization. Unlike traumatic injury, DCM evolves over time, producing distributed pathology across the neuraxis and adaptive but limited neuroplastic responses. Functional deficits arise from both reversible axonal dysfunction and irreversible degeneration, creating a time-sensitive window for intervention. Surgical decompression remains the primary treatment, enabling partial recovery through restoration of perfusion and plasticity. Adjunctive strategies, including neuroprotection, neuromodulation, and remyelination therapies, with rehabilitation, represent promising approaches to enhance recovery by targeting residual neural circuits and the evolving repair environment.
Related Concept Videos
Degenerative Disc Disease ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Neurogenesis and Regeneration of Nervous Tissue
Spinal Cord Injury ll: Pathophysiology
Degenerative Disc Disease I: Introduction